The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sorafenib     Quarter: 2016Q3

Total Drug/Injury Combinations: 167     Number of Pages: 9

DRUGNAME PT EventCount
sorafenib Hypercholesterolaemia 1 view events
SORAFENIB Hypertriglyceridaemia 1 view events
SORAFENIB Hypokalaemia 1 view events
SORAFENIB International normalised ratio increased 1 view events
SORAFENIB Interstitial lung disease 1 view events
SORAFENIB Ischaemic stroke 1 view events
sorafenib Jaundice 1 view events
SORAFENIB Lymphopenia 1 view events
SORAFENIB Malignant neoplasm progression 1 view events
SORAFENIB Metastatic renal cell carcinoma 1 view events
SORAFENIB Multiple organ dysfunction syndrome 1 view events
SORAFENIB Neutropenic infection 1 view events
SORAFENIB Oral herpes 1 view events
sorafenib Pancytopenia 1 view events
SORAFENIB Pneumocystis jirovecii pneumonia 1 view events
SORAFENIB Pneumonia klebsiella 1 view events
SORAFENIB Pneumothorax 1 view events
SORAFENIB Posterior reversible encephalopathy syndrome 1 view events
SORAFENIB Productive cough 1 view events
SORAFENIB Prothrombin time prolonged 1 view events

Total Drug/Injury Combinations: 167     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)